Conjugated linoleic acid (CLA) in milk arises through microbial biohydrogenation of dietary polyunsaturated fatty acids (PUFA) in the rumen, and by the action of mammary Stearoyl-CoA desaturase (Scd).
Conjugated linoleic acid (CLA) is a collective term to describe one or more positional and geometric isomers of linoleic acid (cis-9, cis-12-C 18:2 ). The cis-9, trans-11-C 18:2 isomer is the predominant one in the human diet as a result of microbial biohydrogenation in the rumen. This isomer is produced in ruminants directly as an intermediate during the microbial biohydrogenation of dietary linoleic acid, and endogeneously from trans-vaccenic (trans-11-C 18:1 ) acid in mammary tissue by the action of Stearoyl-CoA desaturase (Scd) (Griinari et al. 2000) . Animal fatcontaining foods, including dairy products, beef, and lamb, are rich sources of CLA (Chin et al. 1992 ; Fritsche and Steinhart 1998; OÕShea et al. 2000) .
CLA has attracted much attention in recent years because of its many potential health benefits. Studies have shown that CLA exhibits anticarcinogenic activity in animal models (Ha et al. 1990 ; Belury et al. 1995; Liew et al. 1995; Ip et al. 1996) and in in vitro studies using a range of human cancer cell lines including mammary (Visonneau et al. 1997 ; Park et al. 2000; Miller et al. 2001) , prostate (Cesano et al. 1998 ; Palombo et al. 2002) and colon (Miller et al. 2001 ; Palombo et al. 2002) . Other properties of CLA include anti-atherogenic activity (Nicolosi et al. 1997 ; Lee et al. 1994 ), the ability to reduce the catabolic effects of immune stimulation (Cook et al. 1993; Millar et al. 1994) , the ability to enhance growth promotion (Chin et al. 1994) , and the ability to reduce body fat (Pariza et al. 1996) .
During biohydrogenation of linoleic acid in the rumen, CLA is produced. This CLA is largely a transient intermediate and is involved as an intermediate in the biohydrogenation pathway to produce stearic acid. A buildup of trans-vaccenic acid occurs (Harfoot and Hazelwood 1988) . Trans-vaccenic acid is also an intermediate in the biohydrogenation of other PUFA (Griinari and Bauman 1999) . Several studies have shown that substantial amounts of trans-vaccenic acid (60-300 g/day) reach the duodenum of lactating cows (Wonsil et al. 1994; Kalscheui et al. 1997a Kalscheui et al. , 1997b . Infusion studies using transvaccenic acid post-ruminally resulted in elevated cis-9, trans-11 CLA in milk-fat, indicating conversion in the mammary gland (Griinari and Bauman 1999) . Several studies have found substantial Scd activity in both mammary and adipose tissue of ruminant animals (Kinsella 1972 ; St. John et al. 1991; Ward et al. 1998; Martin et al. 1999 ). Mammary Scd enzyme, which converts trans-vaccenic acid to cis-9, trans-11 CLA, is believed to be responsible for the formation of the majority of CLA in milk (Griinari and Bauman 1999) .
Animal diet is a major factor affecting the milkfat content of CLA, with dietary supplements containing oils rich in PUFA, such as linoleic and linolenic acids, being the most effective for CLA enrichment of milk. However, substantial variations in the CLA content of milk-fat (ranging from threeto ten fold) of cows on the same dietary treatment have been observed in a number of studies (Jiang et al. 1996; Stanton et al. 1997; Kelly et al. 1998a Kelly et al. , 1998b Lawless et al. 1998 Lawless et al. , 1999 Solomon et al. 2000; White et al. 2001; Peterson et al. 2002) . The reasons for this variation are not well understood. Perhaps ruminally derived CLA is a more important contributor to milk CLA in grass-fed cows. The variation in the CLA content of milk-fat may also be due to a variation in rumen conditions leading to differences in the availability of CLA (or CLA precursors) that escape from the rumen. It might also be caused by differences in mammary Scd activity associated with either regulation of scd gene expression, differences in structure of the enzyme due to gene polymorphisms, or differences in downstream factors that would affect interaction between enzyme and substrate (e.g., phosphorylation) (Peterson et al. 2002) .
The cloned, and characterized. It has been shown in these studies that there is a conserved PUFA response region in all three, and that this includes critical binding sites for sterol response element binding protein (SREBP) and Nuclear factor Y (NF-Y) transcription factors. Sequence comparison of the human and mouse promoters indicated a second region of high homology including the 5¢UTR and basal/ proximal promoter. It has been suggested that there are two different transcription start sites in the human promoter and that these may be dependent on tissue-specific factors (Zhang et al. 2001) .
In this study the role that polymorphisms in the core promoter region of the bovine scd gene might play in influencing regulation of the scd gene was investigated. The bovine core promoter was therefore isolated from genomic DNA by a genome walking approach using primers designed to a genomic database sequence for the bovine Stearoyl-CoA desaturase gene (AF481915) that contained 162 bases of 5¢UTR. Analysis of this promoter sequence identified a number of conserved potential transcription factor binding sites based on comparison with the human and mouse scd promoter regions and interrogation of the TRANSFAC 4.0 database of transcription factor sequences (Wingender et al. 2000) using the MatInspector V2.2 program (Quandt et al. 1995) . Importantly, and for the first time for bovine scd, this core promoter was shown to drive transcription of the reporter gene luciferase in an in vitro mammalian culture system, confirming its presumed function. A number of animals were screened for possible polymorphisms in this promoter region. These included cows producing high milk-fat CLA as a percentage of fatty acid methyl ester (% FAME) content (2.22-2.72), compared with cows yielding a low milk-fat CLA as a percent FAME content (0.81-1.12). Additionally, sequence comparisons of the scd promoter region from a number of different breeds were made.
A longer bovine scd promoter sequence (Accession No. AY241932) is now included in the GenBank database but this was not available at the time of this study; the two promoter sequences were submitted within a very short time of each other.
Materials and methods

Construction of GenomeWalker (GW) libraries.
To obtain the 5¢ flanking sequence of the scd gene, GenomeWalker (GW) libraries were constructed from bovine total genomic DNA using a Universal GenomeWalker kit (Clontech, UK) according to the manufacturerÕs instructions. High-quality genomic DNA was first extracted from cultured lymphoblast cells from a Holstein Friesian animal. Briefly, a cell suspension (15 ml) was centrifuged at 1200 g for 5 min and the pellets mixed and incubated overnight at 37°C in 900 ll 0.2 M EDTA, 0.5% sodium-n-lauroyl sarcosine, and 25 ll of proteinase K (20 mg/ml). Ten microliters of RNase (2 mg/ml) was added to each tube and incubated at 37°C for 1.5 h. The mix was split in two, 200 ll phenol was added and mixed and the mix was incubated for 30 min at 37°C in a rotary mixer. Chloroform (200 ll) was added and then the tubes were shaken vigorously and incubated at 37°C for 1 h in a rotary mixer. Tubes were centrifuged at 16,000 g for 15 min to form two layers. The upper layer was transferred to a fresh tube and two volumes of ice-cold 100% ethanol were added. Tubes were inverted abruptly four times, and at this point a DNA precipitate was obtained. The supernatant was decanted, 100 ll 70% ethanol was added, and the mix was incubated overnight at 21°C in a rotary mixer. Ethanol was decanted off and the pellet was allowed to air-dry. The DNA pellets were resuspended in 50 ll 10 mM Tris-HCl (pH 8.0) containing 1 mM EDTA (TE) buffer and aliquots were checked for integrity on a 0.7% w/v agarose gel containing ethidium bromide (EtBr) (2 lg/ml) gel.
The genomic DNA was digested with four restriction enzymes, DraI, StuI, EcoRV, and PvuII, to create four pools of DNA fragments. Adaptors were ligated onto both ends of these fragments to create four GW libraries: DL1 (DraI), DL2 (StuI), DL3 (EcoRV), and DL4 (PvuII).
Isolation and characterization of the scd promoter from GW libraries. To specifically isolate the scd promoter, genome walking primers pAKGW1 (5¢-GCTCTCAGACACTGGGATCACTTTCTCGG G-3¢) and pAKGW2 (5¢-AACTGAGTGTAGAC TAGTTCCTGAGCCTGC-3¢) were designed using Vector NTI software (InforMax, Inc.) to a genomic database sequence for the bovine scd gene (AF481915) and synthesized by MWG Biotech (Germany). The primary PCR was carried out using 1 ll of the GenomeWalker libraries with the gene-specific primer pAKGW1 and adaptor primer AP1 (from kit). The primary PCR products were diluted 1:50 and used as template for nested PCR with a second gene-specific primer pAKGW2 and a second adaptor primer AP2 (again from kit). The reaction final volume was 50 ll containing Taq DNA polymerase buffer (Invitrogen), 1.5 mM MgCl 2 , 200 lM dNTPs (Promega), 0.3 lM each primer, and 1 U Taq polymerase (Invitrogen). Immediately prior to cycling, 2.5 ll of DMSO was added to the mix. The reaction was amplified for 35 cycles for both the first and second PCR. Cycling was performed in a DNA Engine thermal cycler (MJ Research) and conditions were 95°C for 2 min, followed by 35 cycles of 95°C for 30 sec, 60°C for 30 sec, and 72°C for 3 min. This was followed by a 72°C final extension step for 7 min.
PCR products were directly cloned into the pCR2.1 vector (Invitrogen) and transformed using One Shot Top-10 chemically competent E. coli cells according to the manufacturerÕs instructions (Invitrogen). Colony PCR was performed to identify clones that potentially carried the scd promoter. Small-scale preparations of plasmid DNA were made from these colonies using the procedure outlined by the manufacturer (Sigma). Sequencing of three plasmids (DL1.2, DL1.4, and DL1.8) was performed by MWG Biotech (Germany). The resulting sequences were analyzed using Vector NTI software (InforMax, Inc.). Potential transcription factor binding sites were identified using the MatInspector V2. Luciferase reporter vector construction. pCR2.1-based plasmids containing the putative scd promoter were restriction digested at 37°C to release the fragment and create compatible ends for subcloning into the pGL3-Basic (Promega) promoterless expression vector. The pGL3-Basic vector was digested in the same manner. Ligation reactions were transformed into TAM Ultracomp chemically competent E. coli cells (Active Motif Europe), using instructions recommended by the manufacturer. . Cells were routinely passaged every 3-4 days by washing with phosphate buffered saline (PBS) and treating with 3 ml EDTA-trypsin (Sigma) to remove adherent cells. Cells were maintained in a humidified incubator at 37°C and 5% CO 2 . Cells were grown to 80% confluency and both CHO-K1 and MCF-7 cells were transiently cotransfected with luciferase reporter vectors using Fugene 6 transfection reagent (Roche Diagnostics). Six-well transfection plates were seeded at a concentration of 3 · 10 5 cells per well and incubated overnight at 37°C and 5% CO 2 . pGL3-scd experimental constructs (1 lg) were cotransfected with 25 ng of pRL-SV40 plasmid (Promega) to control for transfection efficiency. Forty-eight hours after transfection, media were removed from the wells, 300 ll Passive Lysis Buffer (Promega) was added, followed by incubation at room temperature for 10 min.
Luciferase assay. The Dual Luciferase Assay Kit (Promega) was used to measure both Renilla and Firefly luciferase expression by the reporter vectors on a Tecan Spectrafluor Plus luminometer using the Magellan software (Tecan). Mean Firefly luciferase activity values were corrected for variations in transfection efficiency using the corresponding mean Renilla luciferase figures. The corrected values were expressed as a percentage of the positive control value (pGL3-Control). Transfection values were a result of three independent transfections, with n = 6, for both cell types.
Analysis of scd promoter polymorphism incidence. A dairy herd (n = 75) had been on a ryegrass diet for a period of six months and their milk was analyzed for fatty acid methyl esters content (% FAME) using the gas liquid chromatography (GLC) method described previously (Stanton et al. 1997 ). FAME content was measured in milk samples from 59 animals taken at the evening milking on two occasions during the grazing season, in July and September. Nine of these 75 cows with consistently low and high milk CLA as a % FAME values over both sampling times were selected for this study. The CLA isomer measured was the cis-9, trans-11 CLA isomer. High CLA animals produced greater than 2.0% FAME (2.22-2.72) in their milk compared with low milk CLA producers of about 1.0% FAME (0.81-1.12). The CLA as a % FAME ranged from 0.81 to 2.72 as quoted in Table 1 and are the mean values of both sampling times.
Genomic DNA, for PCR amplification of the scd promoter fragment, was extracted from whole blood (200 ll) that was collected in heparinized tubes from the coccygeal vein from these nine Holstein Friesian cows and, in addition, from ten cows of different bovine breeds using a Gentra capture column (Gentra). Amplification of the bovine promoter was performed using primers D9Dfor (5¢-TGATGGGG TAGTGAGGAGC-3¢) and D9Drev (5¢-GTTCCT GAGCCTGCTTTTGC-3¢) with 1 ll of genomic DNA as template (200 ng), in a final volume of 50 ll containing Taq DNA polymerase buffer (Invitrogen), 1.5 mM MgCl 2 , 200 lM dNTPs (Promega), 0.3 lM each primer, and 1 U Taq polymerase (Invitrogen). Cycling was performed in a DNA Engine thermal cycler (MJ Research) and conditions were 95°C for 1 min, followed by 35 cycles of 93°C for 1 min, 58.5°C for 1 min, 72°C for 2 min and a final extension step of 72°C for 10 min. PCR products were purified using a PCR purification kit (Qiagen). DNA was eluted in 30 ll of PCR-grade water (Sigma).
Results and discussion
Isolation of the bovine scd promoter. Isolation of the bovine scd promoter was achieved using a genome walking strategy, which involved digestion of bovine genomic DNA with four restriction enzymes, DraI, StuI, EcoRV, and PvuII, to create pools of short DNA fragments of varying lengths. Adaptors were ligated onto the ends of these pools of DNA and PCR was employed to ''walk'' along the genome. Primers for PCR were designed to a bovine genomic sequence for the scd gene (AF481915) that extends approximately 160 bp upstream of the translation initiation codon. PCR products were obtained for libraries DL1 (DraI), DL2 (StuI), and DL3 (EcoRV), but not for the DL4 (PvuII) library. Library DL1 yielded a mixture of fragments but, as these were also the longest, these fragments were purified as a mixed pool and cloned into the pCR2.1 vector. Colony PCR was performed and three plasmids (DL1.2, DL1.4, and DL1.8) were sequenced. BlastN analysis of the three sequences indicated that they were all fragments of the bovine gene and the DL1.4 sequence extended upstream of the bovine genomic database sequence AF481915.
Comparison of bovine, human, and mouse scd promoters. An alignment of the DL1.4 sequence was performed with a human promoter sequence (AF320307) (Zhang et al. 2001 ) and a mouse promoter sequence (M21280) (Fig. 1) . The bovine sequence displayed 67% identity with the human scd sequence and 59% homology with the murine promoter sequence scd1. The bovine sequence has been submitted to the GenBank database (Accession No. AJ555480). Transcription start sites have been iden- tified in both the mouse (Ntambi et al. 1988 ) and human (Zhang et al. 2001 ) genes at 28 bp and 37 bp, respectively, from the proximal TATA box in the bovine sequence. The bovine promoter sequence presented in Fig. 1 is numbered relative to the human transcription start site and extends to )407. Potential transcription factor binding sites were compared with those predicted for the human promoter (Zhang et al. 2001 ). Putative transcription factor binding sites identified using the MatInspector program (Quandt et al., 1995) included nuclear factor Y, octamer binding factor 1, and muscle-specific Mt-binding sites. Comparison of the mouse, human, and bovine sequences identified a number of conserved sequences in two particular regions of the promoters. The first area of conservation occurs between )37 to )119, where there are two conserved TATA sequences (5¢-TTTAAAT-3¢ and 5¢-TAAAA-3¢), a fat-specific element (FSE) (5¢-CTGAGGAAA-3¢) ()77 to )86), and binding sites for the transcription factors AP-1 ()64 to )68), NF-1 ()102 to )109), and HNF4 ()116 to )119). Analysis of the human SCD promoter has shown that for liver and hair follicles, there was a major transcription initiation site 35 nucleotides downstream from the proximal TATA box (Zhang et al. 2001) . It was also shown that another transcription initiation site was present 37 nucleotides downstream from the distal TATA box (Bene et al. 2001) , and it was suggested that the human SCD gene has different start sites that depend on different tissuespecific factors (Zhang et al. 2001 ). The TATA sequence, TTTAAAT, is somewhat unusual: This sequence, where the A in the second position is replaced by a C, T, or G, has been shown to reduce the efficiency of a promoter in in vitro studies (Conchino et al. 1983 ).
The second conserved region occurs at )313 to )390 and has been designated the PUFA response region. Putative binding sites for transcription factors NF-Y ()313 to )317), NF-1 ()333 to )336), NF-Y/NF-1 ()351 to )361), SREBP ()366 to )376), and SP-1 ()386 to )390) are conserved between the three promoter sequences. The PUFA response region present in the bovine sequence is an element previously shown to mediate the downregulation of mouse scd expression in response to PUFA (Waters et al. 1997 ). The sterol response element binding protein (SREBP) has been shown to activate scd genes in the mouse (Shimomura et al. 1998; Tabor et al. 1999) , and it has also been shown that PUFA negatively regulate SREBP mRNA and protein activation (Xu et al. 1999; Yahagi et al. 1999 ). This bovine promoter fragment also contains the CCAAT box at )356 to )360 previously shown to be critical for transcriptional activation in the human promoter (Zhang et al. 2001) . This CCAAT element is also required for full activation of mouse scd1 and scd2 promoters and binds the NF-Y transcription factor (Tabor et al. 1999 ).
Transcription studies in CHO-K1 and MCF-7 cells. To determine whether this 407-bp putative promoter sequence was sufficient to direct transcription, luciferase reporter gene constructs containing the putative promoter cloned into the promoter site of the promoter-less expression vector pGL3-Basic were constructed. A plasmid (pRL-SV40) providing constitutive expression of Renilla luciferase was cotransfected to serve as transfection efficiency control. Two cell types were transfected, a human mammary cell line, MCF-7, and a Chinese hamster ovary cell line, CHO-K1. The CHO-K1 cell line is most commonly used to express mammalian genes in vitro and should contain the general transcription factors necessary for activating transcription of most genes. The human mammary cell line contains more tissue-specific transcription factors and is a more suitable system for studying regulation of a gene expressed in the mammary gland.
The putative promoter showed promoter activity in both CHO-K1 and MCF-7 cell lines (Fig. 2) . Promoter activity was greatest in the mammary MCF-7 cell line, being six fold higher in MCF-7 cells than in CHO-K1 cells. These results indicate that the 407-bp region upstream of the proposed transcription start site is sufficient to direct transcription.
Promoter polymorphism screen. Animals receiving an identical dietary treatment of rye grass for a 6-month period were seen to have milk CLA as a % FAME varying from 0.81 to 2.72. The sample size selected was initially 59 Holstein Friesian cows, from which milk was analyzed for CLA content and subsequently nine cows were selected and divided into two groups of high-and low-CLA producers. There were no differences in the milk yields, feed intake, and milk-fat content of the high-versus the low-CLA animals. However, we did observe that blood glucose and nonessential fatty acids (NEFA) differed significantly between high-and low-CLA cows, with glucose being higher in the blood of the low-CLA group, whereas NEFA was lower in the low-CLA group compared with the high-CLA group. To investigate whether polymorphisms in the bovine scd promoter could explain the considerably large inter-cow variation in milk-fat CLA content, the nucleotide sequences of the promoter region of nine cows (Table 1) were analyzed to identify sequence polymorphisms which maybe related to elevation of milk-fat CLA.
In an attempt to also include an increased genetically diverse element, the promoter region of the scd gene was amplified and sequenced from ten animals of different breeds (high genetic merit Holstein Friesian, low genetic merit Holstein Friesian, Montbeliarde, Normande, Norwegian Red, Irish Friesian, Dutch Friesian, Charlois, Limousin, Kerry). No information regarding the milk CLA status of these animals was available.
The scd promoter region sequences were aligned for these 19 animals (nine animals showing high and low milk CLA as a % FAME and ten animals of varying bovine breeds) and compared to search for any polymorphisms in the area (data not shown). This alignment showed the total absence of any polymorphic sites between the bovine scd promoters of 19 animals. This high conservation may be significant in indicating that the regulation of this gene is under extremely rigid control by transcription factors and high conservation is necessary for full activation.
Conclusions
In conclusion we have isolated and partially characterized the bovine scd promoter. This promoter fragment showed 59% and 67% similarity to both the mouse and human sequences, respectively. Differences in the CLA content of milk from these animals were not a consequence of polymorphisms within the core promoter of this gene. The scd promoter sequence exhibits remarkable sequence conservation not just across high-and low-CLA yielding Holstein Friesians but also across ten different breeds. In contrast, considerable differences were seen between human and mouse sequences which included variation in nonbinding regions and binding regions for AP-1, SP-1, and NF-KB transcription factors. Consequently, the observed variation in the levels of milk CLA produced in the Holstein Friesian animals may be explained by differences in ruminant synthesis of CLA or CLA precursors, polymorphisms in the coding sequences of the bovine scd gene, or differences in the regulatory proteins themselves, an area that requires further investigation.
